Pharmacodynamic characterization of the electroencephalographic effects of thiopental in rats
- 48 Downloads
We have developed a chronically instrumented rat model that uses changes in electroencephalographic waveforms to estimate continuously the degree of central nervous system (CNS) depression induced by thiopental. Such changes were subject to aperiodic signal analysis, a technique that breaks down the complex EEG into a series of discreet neurologic “events” which are then quantitated as waves/sec. We thus obtained a continuous measure of CNS drug effect. In addition we continuously recorded central arterial blood pressure and heart rate and monitored ventilatory status using arterial blood gas determinations. We also determined, with frequent arterial blood sampling, the distribution and elimination of thiopental in individual animals. The time lag occurring in the curve representing arterial concentration of thiopental vs. EEG effect suggests that arterial plasma is not kinetically equivalent to the EEC effect site. Application of semiparametric pharmacodynamic modeling techniques enabled us to estimate equilibration rate constant (Keo for concentrations of thiopental between arterial plasma and the effect site. The half-life for equilibration of thiopental with the EEG (CNS) effect was less than 80 sec. Knowledge of the rate of equilibration permitted characterization of the relationship between the steady state plasma concentrations and CNS effect of thiopental, as measured by activation and slowing of the EEG. At concentrations of thiopental below 5 gmg/ml, EEG activity was 180% higher than during the baseline awake state. Thiopental produced an activated EEG over more than 20% of the concentration-effect relationship. Further increases in the concentration of thiopental at the site of effect depressed EEG activity progressively until complete suppression of the EEG signal occurred (at which time, the concentration was approximately 80 μg/ml). This report describes our model and its application to the assessment of the pharmacodynamics of thiopental as manifested by changes on the EEG.
Key wordsanesthetics thiopental electroencephalogram biphasic pharmacodynamic model
Unable to display preview. Download preview PDF.
- 1.M. Danhof and G. Levy. Kinetics of drug action in disease states. I. Effects of infusion on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex.J. Pharmacol. Exp. Ther. 229:33–50 (1984).Google Scholar
- 4.S. Wonwimolruk and G. Levy. Kinetics of disease states. XX. Effect of acute starvation on the pharmacodynamics of phenobarbital, ethanol and pentylenetetrazol in rats and effect of refeeding and diet composition.J. Pharmacol. Exp. Ther. 242:166–172 (1987).Google Scholar
- 12.W. F. Ebling, L. Mills-Williams, S. R. Harapat, and D. R. Stanski. A high-performance liquid chromatographic method for determining thiopental concentrations in twelve rat tissues: Application to physiologic modeling of disposition of barbiturate.J. Chromatog. 490:339–353 (1989).CrossRefGoogle Scholar
- 15.N. A. Lassen and W. Perl. InTracer Kinetic Methods in Medical Physiology, Raven Press, New York, 1979, pp. 62–101.Google Scholar
- 16.L. B. Sheiner. ELSFIT-A program for the extended least squares fit to individual pharmacokinetic data. Technical Report, Division of Clinical Pharmacology, University of California, San Francisco, CA, February 1981.Google Scholar
- 17.M. Gibaldi and D. Perrier. InPharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982, p. 68, Eq. 2.69.Google Scholar
- 19.M. C. Demetrescu. The aperiodic character of the electroencephalogram.Physiologist 18:189 (1975).Google Scholar